BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for ASLAN Pharmaceuticals Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 10:22 am Purchase |
2023-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN |
BIOTECHNOLOGY VALUE FUND L P | 5,418,122 9.990% |
5,418,122 (New Position) |
Filing |